Elicio Therapeutics Inc (ELTX)
8.85
-0.35
(-3.80%)
USD |
NASDAQ |
May 01, 16:00
8.75
-0.10
(-1.13%)
After-Hours: 20:00
Elicio Therapeutics Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -22.86M |
| June 30, 2023 | -17.64M |
| December 31, 2022 | |
| September 30, 2022 | -15.46M |
| Date | Value |
|---|---|
| June 30, 2022 | -10.08M |
| March 31, 2021 | -6.149M |
| March 31, 2020 | -2.572M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-22.86M
Minimum
Sep 2023
-2.572M
Maximum
Mar 2020
-12.46M
Average
-12.77M
Median
Free Cash Flow (Quarterly) Benchmarks
| Immuneering Corp | -11.95M |
| Oragenics Inc | -1.102M |
| Outlook Therapeutics Inc | -13.03M |
| Amylyx Pharmaceuticals Inc | 13.20M |
| NovaBay Pharmaceuticals Inc | -0.316M |